IKT - inhibikase.com Sof foyda bo'yicha sotuv rentabelligi

Inhibikase Therapeutics Inc - IKT emitenti grafik logotipi

Yillik sof marja foyda dinamikasini namoyish etadi, bunda 0.00 ushbu ko'rsatkichning joriy holatini tavsiflaydi. Inhibikase Therapeutics (IKT) kompaniyasining o'sishi Parkinson kasalligi terapiyasi sinovlarining muvaffaqiyati va mavjud kapitalga bog'liq. Barqaror savdo hajmi patentlar bilan himoyalangan butun umrlik neyrodegeneratsiya davolash kurslari orqali ta'minlanadi. Spekulyativ salohiyat kelajakdagi tijorat daromadlarini belgilovchi kinaza inhibitorlarining samaradorligiga asoslangan.

Inhibikase Pharma (IKT) - Sof foyda normasi 04.07.2022dan 20.11.2026gacha

Inhibikase (IKT) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi statistikasi:
Kompaniyaning dastlabki tahlili:Inhibikase Therapeutics
Inhibikase Therapeutics Inc ishlab chiqargan mahsulot

Fundamental aktivlarni skrining qilish bozor shovqini va haqiqiy kapitalni boshqarish samaradorligi o'rtasida aniq farqni talab qiladi. Tijoriy daromadlilikni tahlil qilishda investor sof foyda marjasini baholaydi, bu esa hozirda preklinik bosqichda bo'lgan va minimal ekologik izga ega Inhibikase Therapeutics (IKT) uchun operatsion biznes daromadliligi emas, balki resurslarni sarflash bosqichini aks ettiradi.

Raqobatdosh kompaniyalar

BIIB: Sotuvning sof marjinal rentabelligi|Sof marja Neurocrine Biosciences Inc (NBIX)|RGC (Regencell Corp) - Sotuvning sof marjinal rentabelligi|AXSM: Sof foyda normasi|Sof marja acadia-pharm.com (ACAD)|Sotuvning sof marjinal rentabelligi Xenon Pharmaceuticals (XENE)|Sof marja Viking Therapeutics VKTX|Sof foyda normasi SUPN|CPRX - Sof marja|Sof marja Denali Therapeutics|HRMY: Sotuvning sof marjinal rentabelligi|Biohaven - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi AMLX|Trevi Therapeutics, Inc. (TRVI) - Kompaniya sotuv marjasi|Sof foyda bo'yicha sotuv rentabelligi PRAX (Praxis Medicines)|Anavex Corp - Sotuvning sof rentabelligi|Sof marja CeriBell CBLL|Kompaniya sotuv marjasi Prothena Biosciences (PRTA)|ALEC: Sof foyda bo'yicha sotuv rentabelligi|ANNX - Sotuvning sof marjinal rentabelligi|Omeros Corp. (OMER) - Sof marja|Sof marja Neurogene Inc. (NGNE)|Sof foyda bo'yicha sotuv rentabelligi ACIU|Sof marja VYGR|Sof marja Neumora (NMRA)|SCLX - Sof marja|Sotuvning sof marjinal rentabelligi TVGN (Tevogen Bio Holdings Inc.)|Sof foyda normasi ACOG|Cognition Therapeutics Inc. - Sotuvning sof marjinal rentabelligi|SAVA: Sof marja|Assertio Therapeutics (ASRT) - Sof marja|Sof marja Coya Therapeutics Inc (COYA)|Sof marja Vistagen|Sotuvning sof rentabelligi OVID (ovidrx.com)|Sof marja Acumen Pharmaceuticals, Inc. (ABOS)|CRVO - Sof marja|Alterity Therapeutics Ltd. - Sof foyda bo'yicha sotuv rentabelligi|CLNN - Sof foyda bo'yicha sotuv rentabelligi|PEPG - Sof marja|Kompaniya sotuv marjasi jupiterneurosciences.com JUNS|Relmada Therapeutics (RLMD) - Sof marja|ANVS (Annovis Bio, Inc.) - Sof marja|Sof marja gracetx.com|Sotuvning sof marjinal rentabelligi Firefly Neuroscience, Inc.|Sof marja ANEW Medical (KLTO)|NRSN - Sof marja|Sotuvning sof marjinal rentabelligi RVPH (Reviva Pharmaceuticals Holdings Inc.)|Kompaniyaning sof rentabelligi MTVA (metaviatx.com)|NeurAxis Inc. - Sotuvning sof marjinal rentabelligi|Kompaniya sotuv marjasi heliusmedical.com HSDT|PASG: Sotuvning sof marjinal rentabelligi|Neuphoria - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi NERV|ATHA: Sof foyda normasi|Sof marja Addex Therapeutics Ltd (ADXN)|ALZN (Alzamend Neuro Inc.) - Sof foyda normasi|Sotuvning sof marjinal rentabelligi CYCN (cyclerion.com)|Sof foyda bo'yicha marjinallik Protagenic|KTTA: Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi CRGT (cortigent.com)|ATXI: Sotuvning sof marjinal rentabelligi|BCLI (BrainStorm Cell Therapeutics) - Sof marja|CARA (Cara Therapeutics Inc.) - Sotuvning sof marjinal rentabelligi|Sof marja CHRO|Sof foyda bo'yicha sotuv rentabelligi ELYM (Eliem Therapeutics)|Sof marja ITCI (Intra-Cellular Therapies Inc.)|Sotuvning sof marjinal rentabelligi LBPH (Longboard Pharma)|Sotuvning sof marjinal rentabelligi Marinus Pharmaceuticals Inc MRNS|NKGen Biotech Corp - Sotuvning sof marjinal rentabelligi|Sof foyda normasi NRBO (NeuroBo Pharma)|SAGE (Sage Therapeutics, Inc) - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof rentabelligi SNPX|Sof foyda bo'yicha sotuv rentabelligi TRVN|Sof marja VIGL|Sotuvning sof marjinal rentabelligi WENA|Kompaniya sotuv marjasi Cerevel